It's Time For-Nonprofit Organization-Anaheim-Researching Type 1 Diabetes
See full list of Video Credits http://broadcaster.beazil.net/public/credits/youtube/videos/42468 Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
While people with T1D rely on insulin therapy to control their blood sugar, insulin is not a cure nor does it prevent the possibility of the disease’s serious side effects. Even with intensive disease management, a significant portion of their day is still spent with high or low blood-sugar levels, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, kidney disease and amputation. JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. The most popular attraction in the Anaheim area is Disneyland because it offers rides and attractions for people of all ages. From navigating the sea with pirates, running from the abominable snowman of Matterhorn Mountain, or visiting with the friendly characters of the Disney films, there is something for everyone at this great park. While Disneyland has great rides, some might find they need more adventure and those looking for more thrills and screams should visit Disney’s California Adventure right next door. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To summarize, let’s point out the major points:
plasma glucose criteria,Immune System,Glucose,ketosis,T1D Staging,insulin analogues,Promise to Remember Me,donate to help,Veterans Affairs Diabetes Trial,JDRF lobbies,Affects of Diabetes,Casual Plasma Glucose Test,NovoLog,Education,Microvascular Complications,contribute,Estrogen in Type 1 Diabetes,make a contribution,Blood Glucose Meters,DonorDrive,fundraising,methods to cure T1D,diabetes management,LDL Cholesterol,Prevent Autoimmunity,insulin independent remission,Countdown,Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation Trial,Team Cure Diabetes,insulin lispro,insufficient insulin production,Recipe Swap,Carb Counting,The Kumamoto Study,ADVANCE Trial,A1C Limitations,tolbutamide,funding research,insulin adjustment,insulin-dependent diabetes mellitus,Food insecurity (FI),Treating Type 1,HAPO Study,Device,high blood glucose,glyburide,Derek Rapp,insulin dependent diabetes,Research,insulin pen,early detection of diabetes,certified diabetes educator,Type 2 Diabetes,Medical Device,Ketoacidosis,American Diabetes Association,Children’s Congress,VLDL cholesterol,fundraise,Research funding,The Ride to Cure Diabetes,LDL cholesterol,Insulin Pump Therapy,Diabetes.